Di Lei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Di Lei has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Cuifang Fan
Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan 430060, China
3 shared publications Congcong Fang
Department of Neurosurgery, Renmin Hospital of Wuhan University, China
2 shared publicationsXiaolei Xue
The Fifth Affiliated Hospital of Xinjiang Medical University
2 shared publicationsYonghao Sun
Fujian Provincial Key Laboratory of Reproductive Health Research, School of Medicine, Xiamen University, Xiamen, China
2 shared publicationsChuanhui Guo
State Key Laboratory of Animal Biotech Breeding College of Biological Sciences China Agricultural University Beijing China
1 shared publicationCuifang Fan
Department of obstetrics Renmin Hospital of Wuhan University Wuhan China
1 shared publication
Latest Publications
- Open Access
- 16 June 2026
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 54 (6)
Association of liver enzyme abnormalities and tobacco exposure with unexplained recurrent spontaneous abortion risk: A case–control study
Objective: Unexplained recurrent spontaneous abortion is a multifactorial condition with an unclear etiology. This study aimed to investigate the relationship between liver function biomarkers and unexplained recurrent spontaneous abortion and explore interactions with tobacco exposure and body mass index. Methods: A retrospective case–control study was conducted on 2126 pregnant women, including 602 with unexplained recurrent spontaneous abortion and 1524 who served as controls. Liver enzyme indicators (alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, and alkaline phosphatase) were assessed, and multivariate logistic regression models were applied to analyze their association with unexplained recurrent spontaneous abortion. Interaction analyses were performed to evaluate combined effects of liver enzyme abnormalities, tobacco exposure, and body mass index. Results: Liver enzyme abnormalities (alanine aminotransferase level >32 U/L or aspartate aminotransferase level >28 U/L) were significantly associated with increased unexplained recurrent spontaneous abortion risk (adjusted odds ratio = 2.15, 95% confidence interval: 1.68–2.76). A significant interaction between alanine aminotransferase elevation and tobacco exposure was observed (p < 0.001). Among non-exposed women, elevated alanine aminotransferase levels were associated with an odds ratio of 1.8 (95% confidence interval: 1.2–2.7), whereas among tobacco-exposed women, the odds ratio was 5.2 (95% confidence interval: 3.1–8.7) ( p for interaction (p = 0.179). Conclusions: Elevated alanine aminotransferase and aspartate aminotransferase levels are independently associated with unexplained recurrent spontaneous abortion, and tobacco exposure significantly strengthened this association. These findings suggest that liver function abnormalities and tobacco exposure are associated with unexplained recurrent spontaneous abortion risk. However, given the limitations associated with tobacco exposure measurement, these findings should be interpreted with caution.
- 16 June 2026
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 54 (6)
Open AccessAssociation of liver enzyme abnormalities and tobacco exposure with unexplained recurrent spontaneous abortion risk: A case–control study
Objective: Unexplained recurrent spontaneous abortion is a multifactorial condition with an unclear etiology. This study aimed to investigate the relationship between liver function biomarkers and unexplained recurrent spontaneous abortion and explore interactions with tobacco exposure and body mass index. Methods: A retrospective case–control study was conducted on 2126 pregnant women, including 602 with unexplained recurrent spontaneous abortion and 1524 who served as controls. Liver enzyme indicators (alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, and alkaline phosphatase) were assessed, and multivariate logistic regression models were applied to analyze their association with unexplained recurrent spontaneous abortion. Interaction analyses were performed to evaluate combined effects of liver enzyme abnormalities, tobacco exposure, and body mass index. Results: Liver enzyme abnormalities (alanine aminotransferase level >32 U/L or aspartate aminotransferase level >28 U/L) were significantly associated with increased unexplained recurrent spontaneous abortion risk (adjusted odds ratio = 2.15, 95% confidence interval: 1.68–2.76). A significant interaction between alanine aminotransferase elevation and tobacco exposure was observed (p < 0.001). Among non-exposed women, elevated alanine aminotransferase levels were associated with an odds ratio of 1.8 (95% confidence interval: 1.2–2.7), whereas among tobacco-exposed women, the odds ratio was 5.2 (95% confidence interval: 3.1–8.7) ( p for interaction (p = 0.179). Conclusions: Elevated alanine aminotransferase and aspartate aminotransferase levels are independently associated with unexplained recurrent spontaneous abortion, and tobacco exposure significantly strengthened this association. These findings suggest that liver function abnormalities and tobacco exposure are associated with unexplained recurrent spontaneous abortion risk. However, given the limitations associated with tobacco exposure measurement, these findings should be interpreted with caution.
- 17 July 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 362, 615-622
Association between gut microbiota and postpartum depression: A bidirectional Mendelian randomization study
- 17 July 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 362, 615-622
Association between gut microbiota and postpartum depression: A bidirectional Mendelian randomization study
- Open Access
- 27 June 2024
- Published by Springer Nature in BMC Psychiatry
- Vol. 24 (1) , 1-13
The relationship of immune cells with autism spectrum disorder: a bidirectional Mendelian randomization study
Background: Observational studies have indicated a correlation between immunological inflammation and the risk of autism spectrum disorder (ASD). However, the causal relationship between immunological inflammation and ASD remains uncertain. Methods: Immunity-wide data sources were retrieved from the GWAS catalog. Genetic summary data on ASD were retrieved from two independent GWAS. We performed two independent bi-directional, two-sample Mendelian randomization (MR) analyses and a meta-analysis based on the two independent MR estimates to assess the causal relationship between ASD and immune cell signatures. Results: We have discovered 26 potential correlations between genetic predisposition in the immunophenotypes and ASD. The meta-analysis of the two inverse variance weighted (IVW)-produced estimates provided further evidence supporting the potential causal relationship between immunophenotypes and ASD. Based on the findings of the reverse MR analysis, it was determined that there are two potential negative causal relationships between ASD and immunophenotypes. However, the meta-analysis of the two IVW-derived MR estimates indicated that immunophenotypes were not significantly influenced by ASD (OR = 0.87, 95% CI = 0.73 -1.03, P = 0.09; OR = 0.91, 95% CI = 0.81–1.01, P = 0.08). Conclusions: This study expanded immune cell subtypes that were potentially causally associated with ASD risk as well as identified ASD-specific immune cell subtypes. The discovery has the potential to lead to earlier detection and more effective treatment techniques.
- 27 June 2024
- Published by Springer Nature in BMC Psychiatry
- Vol. 24 (1) , 1-13
Open AccessThe relationship of immune cells with autism spectrum disorder: a bidirectional Mendelian randomization study
Background: Observational studies have indicated a correlation between immunological inflammation and the risk of autism spectrum disorder (ASD). However, the causal relationship between immunological inflammation and ASD remains uncertain. Methods: Immunity-wide data sources were retrieved from the GWAS catalog. Genetic summary data on ASD were retrieved from two independent GWAS. We performed two independent bi-directional, two-sample Mendelian randomization (MR) analyses and a meta-analysis based on the two independent MR estimates to assess the causal relationship between ASD and immune cell signatures. Results: We have discovered 26 potential correlations between genetic predisposition in the immunophenotypes and ASD. The meta-analysis of the two inverse variance weighted (IVW)-produced estimates provided further evidence supporting the potential causal relationship between immunophenotypes and ASD. Based on the findings of the reverse MR analysis, it was determined that there are two potential negative causal relationships between ASD and immunophenotypes. However, the meta-analysis of the two IVW-derived MR estimates indicated that immunophenotypes were not significantly influenced by ASD (OR = 0.87, 95% CI = 0.73 -1.03, P = 0.09; OR = 0.91, 95% CI = 0.81–1.01, P = 0.08). Conclusions: This study expanded immune cell subtypes that were potentially causally associated with ASD risk as well as identified ASD-specific immune cell subtypes. The discovery has the potential to lead to earlier detection and more effective treatment techniques.
- Open Access
- 12 March 2024
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 26 (5) , 474-482
The causal role of circulating immunity‐inflammation in preeclampsia: A Mendelian randomization
Patients with systemic autoimmune diseases, such as systemic lupus erythematosus, were at a higher risk for preeclampsia. The causal relationship between immunological inflammation and preeclampsia (PE) remains uncertain. We aimed to investigate the causal relationship between circulating immune inflammation and PE. Genetically predicted blood immune cells and circulating inflammatory proteins were identified using two genome‐wide association studies (GWAS). We used a two‐sample Mendelian randomization (MR) method to determine whether circulating immunological inflammation causes PE. Our findings indicated that ten immunophenotypes were identified to be significantly associated with PE risk: CD62L‐ Dendritic Cell Absolute Count, CD86+ myeloid Dendritic Cell %Dendritic Cell, CD62L‐ myeloid Dendritic Cell Absolute Count, CD86+ myeloid Dendritic Cell Absolute Count, CD62L‐ myeloid Dendritic Cell %Dendritic Cell, CD62L‐ CD86+ myeloid Dendritic Cell %Dendritic Cell, CD62L‐ CD86+ myeloid Dendritic Cell Absolute Count, CD16 on CD14+ CD16+ monocyte, HLA DR+ Natural Killer Absolute Count, and T cell Absolute Count. Ninety‐one inflammation‐related proteins had no statistically significant effect on PE following false discovery rate (FDR) correction. Certain proteins exhibited unadjusted low p‐values that merited mention. These proteins include interleukin‐10 (OR = 0.76, 95%CI = 0.63–0.93, p = .006), fibroblast growth factor 21 (OR = 1.23, 95%CI = 1.01–1.47, p = .035), and Caspase 8 (OR = 0.65, 95%CI = 0.50–0.85, p = .001). The ELISA analysis demonstrated elevated levels of FGF‐21 and decreased levels of IL‐10 and Caspase‐8 in the plasma of patients with PE. These findings reveal that immunophenotypes and circulating inflammatory proteins may induce PE, confirming the importance of peripheral Immunity‐Inflammation in PE. The discovery has the potential to lead to earlier detection and more effective treatment techniques.
- 12 March 2024
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 26 (5) , 474-482
Open AccessThe causal role of circulating immunity‐inflammation in preeclampsia: A Mendelian randomization
Patients with systemic autoimmune diseases, such as systemic lupus erythematosus, were at a higher risk for preeclampsia. The causal relationship between immunological inflammation and preeclampsia (PE) remains uncertain. We aimed to investigate the causal relationship between circulating immune inflammation and PE. Genetically predicted blood immune cells and circulating inflammatory proteins were identified using two genome‐wide association studies (GWAS). We used a two‐sample Mendelian randomization (MR) method to determine whether circulating immunological inflammation causes PE. Our findings indicated that ten immunophenotypes were identified to be significantly associated with PE risk: CD62L‐ Dendritic Cell Absolute Count, CD86+ myeloid Dendritic Cell %Dendritic Cell, CD62L‐ myeloid Dendritic Cell Absolute Count, CD86+ myeloid Dendritic Cell Absolute Count, CD62L‐ myeloid Dendritic Cell %Dendritic Cell, CD62L‐ CD86+ myeloid Dendritic Cell %Dendritic Cell, CD62L‐ CD86+ myeloid Dendritic Cell Absolute Count, CD16 on CD14+ CD16+ monocyte, HLA DR+ Natural Killer Absolute Count, and T cell Absolute Count. Ninety‐one inflammation‐related proteins had no statistically significant effect on PE following false discovery rate (FDR) correction. Certain proteins exhibited unadjusted low p‐values that merited mention. These proteins include interleukin‐10 (OR = 0.76, 95%CI = 0.63–0.93, p = .006), fibroblast growth factor 21 (OR = 1.23, 95%CI = 1.01–1.47, p = .035), and Caspase 8 (OR = 0.65, 95%CI = 0.50–0.85, p = .001). The ELISA analysis demonstrated elevated levels of FGF‐21 and decreased levels of IL‐10 and Caspase‐8 in the plasma of patients with PE. These findings reveal that immunophenotypes and circulating inflammatory proteins may induce PE, confirming the importance of peripheral Immunity‐Inflammation in PE. The discovery has the potential to lead to earlier detection and more effective treatment techniques.
- Open Access
- 7 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (6) , 5111
The Enzyme 15-Hydroxyprostaglandin Dehydrogenase Inhibits a Shift to the Mesenchymal Pattern of Trophoblasts and Decidual Stromal Cells Accompanied by Prostaglandin Transporter in Preeclampsia
Preeclampsia (PE) is a pregnancy complication beginning after 20 weeks of pregnancy that involves high blood pressure (systolic > 140 mmHg or diastolic > 90 mmHg), with or without proteinuria. Insufficient trophoblast invasion and abnormal decidualization are involved in PE development. However, whether unhealthy placenta and decidua have the same biological activities is unclear. The enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH; encoded by HPGD) degrades prostaglandin, and prostaglandin transporter (PGT), as a candidate molecule of prostaglandin carriers, helps transport prostaglandin into cells. Whether 15-PGDH and PGT are involved in PE has not been researched. In this study, we investigated the shared pathogenesis of foetal placenta and maternal decidua from the perspective of epithelial–mesenchymal transition (EMT)/mesenchymal–epithelial transition (MET) and explored the combined effects of 15-PGDH and PGT on the EMT/MET of trophoblasts and decidual stromal cells (DSCs). Here, we demonstrated that placental development and decidualization both involved EMT/MET. In PE, both trophoblasts and DSCs show more epithelial patterns. Moreover, 15-PGDH expression was downregulated in the placentas but upregulated in the deciduas of PE patients. Inhibiting 15-PGDH promotes a shift to a mesenchymal pattern of trophoblasts and DSCs depending on the PGT-mediated transport of prostaglandin E2 (PGE2). In conclusion, our results showed that inhibiting 15-PGDH promotes a shift to the mesenchymal pattern of trophoblasts and DSCs and may provide a new and alternative therapy for the treatment of PE.
- 7 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (6) , 5111
Open AccessThe Enzyme 15-Hydroxyprostaglandin Dehydrogenase Inhibits a Shift to the Mesenchymal Pattern of Trophoblasts and Decidual Stromal Cells Accompanied by Prostaglandin Transporter in Preeclampsia
Preeclampsia (PE) is a pregnancy complication beginning after 20 weeks of pregnancy that involves high blood pressure (systolic > 140 mmHg or diastolic > 90 mmHg), with or without proteinuria. Insufficient trophoblast invasion and abnormal decidualization are involved in PE development. However, whether unhealthy placenta and decidua have the same biological activities is unclear. The enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH; encoded by HPGD) degrades prostaglandin, and prostaglandin transporter (PGT), as a candidate molecule of prostaglandin carriers, helps transport prostaglandin into cells. Whether 15-PGDH and PGT are involved in PE has not been researched. In this study, we investigated the shared pathogenesis of foetal placenta and maternal decidua from the perspective of epithelial–mesenchymal transition (EMT)/mesenchymal–epithelial transition (MET) and explored the combined effects of 15-PGDH and PGT on the EMT/MET of trophoblasts and decidual stromal cells (DSCs). Here, we demonstrated that placental development and decidualization both involved EMT/MET. In PE, both trophoblasts and DSCs show more epithelial patterns. Moreover, 15-PGDH expression was downregulated in the placentas but upregulated in the deciduas of PE patients. Inhibiting 15-PGDH promotes a shift to a mesenchymal pattern of trophoblasts and DSCs depending on the PGT-mediated transport of prostaglandin E2 (PGE2). In conclusion, our results showed that inhibiting 15-PGDH promotes a shift to the mesenchymal pattern of trophoblasts and DSCs and may provide a new and alternative therapy for the treatment of PE.